{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:58:34Z","timestamp":1772805514778,"version":"3.50.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40272-019-00349-3","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T05:46:02Z","timestamp":1568094362000},"page":"345-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Bullous Diseases in Children: A Review of Clinical Features and Treatment Options"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-892X","authenticated-orcid":false,"given":"Brittney","family":"Schultz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-3415","authenticated-orcid":false,"given":"Kristen","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"issue":"4","key":"349_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1525-1470.1997.tb00954.x","volume":"14","author":"WL Weston","year":"1997","unstructured":"Weston WL, Morelli JG, Huff JC. Misdiagnosis, treatments, and outcomes in the immunobullous diseases in children. Pediatr Dermatol. 1997;14(4):264\u201372.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"349_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/pde.12684","volume":"32","author":"YL Kong","year":"2015","unstructured":"Kong YL, Lim YL, Chandran NS. Retrospective study on autoimmune blistering disease in paediatric patients. Pediatr Dermatol. 2015;32(6):845\u201352. https:\/\/doi.org\/10.1111\/pde.12684 .","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"349_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","volume":"152","author":"JD Fine","year":"2016","unstructured":"Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry. JAMA Dermatol. 2016;152(11):1231\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2016.2473 .","journal-title":"JAMA Dermatol"},{"issue":"2","key":"349_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40257-017-0257-1","volume":"18","author":"Z Ren","year":"2017","unstructured":"Ren Z, Hsu DY, Silverberg NB, Silverberg JI. The inpatient burden of autoimmune blistering disease in US children: analysis of nationwide inpatient sample data. Am J Clin Dermatol. 2017;18(2):287\u201397. https:\/\/doi.org\/10.1007\/s40257-017-0257-1 .","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"349_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5021\/ad.2016.28.1.6","volume":"28","author":"IK Jeon","year":"2016","unstructured":"Jeon IK, On HR, Kim SC. Quality of life and economic burden in recessive dystrophic epidermolysis bullosa. Ann Dermatol. 2016;28(1):6\u201314. https:\/\/doi.org\/10.5021\/ad.2016.28.1.6 .","journal-title":"Ann Dermatol"},{"issue":"5","key":"349_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1586\/edm.09.39","volume":"4","author":"E Antiga","year":"2009","unstructured":"Antiga E, Torchia D, Caproni M, Fabbri P. Linear immunoglobulin A bullous dermatosis. Expert Rev Dermatol. 2009;4(5):495\u2013508.","journal-title":"Expert Rev Dermatol"},{"issue":"3","key":"349_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0738-081X(91)90031-F","volume":"9","author":"S Jab\u0142o\u0144ska","year":"1991","unstructured":"Jab\u0142o\u0144ska S, Chorzelski TP, Rosinska D, Maciejowska E. Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). Clin Dermatol. 1991;9(3):393\u2013401.","journal-title":"Clin Dermatol"},{"issue":"5 Pt 1","key":"349_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","volume":"19","author":"F Wojnarowska","year":"1988","unstructured":"Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19(5 Pt 1):792\u2013805.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"349_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jid.2017.12.035","volume":"138","author":"J Yamagami","year":"2018","unstructured":"Yamagami J, Nakamura Y, Nagao K, Funakoshi T, Takahashi H, Tanikawa A, et al. Vancomycin mediates IgA autoreactivity in drug-induced linear IgA bullous dermatosis. J Invest Dermatol. 2018;138(7):1473\u201380. https:\/\/doi.org\/10.1016\/j.jid.2017.12.035 .","journal-title":"J Invest Dermatol"},{"issue":"5","key":"349_CR10","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1111\/j.1525-1470.2007.00438.x","volume":"24","author":"JC Ho","year":"2007","unstructured":"Ho JC, Ng PL, Tan SH, Giam YC. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid. Pediatr Dermatol. 2007;24(5):E40\u20133. https:\/\/doi.org\/10.1111\/j.1525-1470.2007.00438.x .","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"349_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bcp.13827","volume":"85","author":"B Garel","year":"2019","unstructured":"Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, T\u00e9tart F, Bensaid B, et al. Drug-induced linear IgA bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases. Br J Clin Pharmacol. 2019;85(3):570\u20139. https:\/\/doi.org\/10.1111\/bcp.13827 .","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"349_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1525-1470.1993.tb00371.x","volume":"10","author":"J Handley","year":"1993","unstructured":"Handley J, Shields M, Dodge J, Walsh M, Bingham A. Chronic bullous disease of childhood and ulcerative colitis. Pediatr Dermatol. 1993;10(3):256\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"349_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2133.2004.05850.x","volume":"150","author":"CS Wong","year":"2004","unstructured":"Wong CS, Arkwright PD, Rieux-Laucat F, Cant AJ, Stevens RF, Judge MR. Childhood linear IgA disease in association with autoimmune lymphoproliferative syndrome. Br J Dermatol. 2004;150(3):578\u201380. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.05850.x .","journal-title":"Br J Dermatol"},{"issue":"6","key":"349_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00128071-200708060-00010","volume":"8","author":"M Polat","year":"2007","unstructured":"Polat M, Lenk N, K\u00fcrek\u00e7i E, Ozta\u015f P, Art\u00fcz F, Alli N. Chronic bullous disease of childhood in a patient with acute lymphoblastic leukemia: possible induction by a drug. Am J Clin Dermatol. 2007;8(6):389\u201391. https:\/\/doi.org\/10.2165\/00128071-200708060-00010 .","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"349_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3315\/jdcr.2010.1053","volume":"4","author":"M Nantel-Battista","year":"2010","unstructured":"Nantel-Battista M, Al Dhaybi R, Hatami A, Marcoux D, Desroches A, Kokta V. Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole. J Dermatol Case Rep. 2010;4(3):33\u20135. https:\/\/doi.org\/10.3315\/jdcr.2010.1053 .","journal-title":"J Dermatol Case Rep"},{"issue":"4","key":"349_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pde.12859","volume":"33","author":"CY Zhao","year":"2016","unstructured":"Zhao CY, Chiang YZ, Murrell DF. Neonatal autoimmune blistering disease: a systematic review. Pediatr Dermatol. 2016;33(4):367\u201374. https:\/\/doi.org\/10.1111\/pde.12859 .","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"349_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.det.2011.08.013","volume":"29","author":"EM Mintz","year":"2011","unstructured":"Mintz EM, Morel KD. Treatment of chronic bullous disease of childhood. Dermatol Clin. 2011;29(4):699\u2013700. https:\/\/doi.org\/10.1016\/j.det.2011.08.013 .","journal-title":"Dermatol Clin"},{"issue":"5","key":"349_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2230.1990.tb02116.x","volume":"15","author":"S Edwards","year":"1990","unstructured":"Edwards S, Wojnarowska F. Chronic bullous disease of childhood in three patients of Polynesian extraction. Clin Exp Dermatol. 1990;15(5):367\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"349_CR19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.0926-9959.2001.00269-9.x","volume":"15","author":"N Khanna","year":"2001","unstructured":"Khanna N, Pandhi RK, Gupta S, Singh MK. Response of chronic bullous dermatosis of childhood to a combination of dapsone and nicotinamide. J Eur Acad Dermatol Venereol. 2001;15(4):368.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"349_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/000155502320323351","volume":"82","author":"R Gl\u00e4ser","year":"2002","unstructured":"Gl\u00e4ser R, Sticherlin M. Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil. Acta Derm Venereol. 2002;82(4):308\u20139. https:\/\/doi.org\/10.1080\/000155502320323351 .","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"349_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2230.2005.01741.x","volume":"30","author":"C Talhari","year":"2005","unstructured":"Talhari C, Mahnke N, Ruzicka T, Megahed M. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent. Clin Exp Dermatol. 2005;30(3):297\u20138. https:\/\/doi.org\/10.1111\/j.1365-2230.2005.01741.x .","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"349_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archderm.139.9.1121","volume":"139","author":"J Farley-Li","year":"2003","unstructured":"Farley-Li J, Mancini AJ. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol. 2003;139(9):1121\u20134. https:\/\/doi.org\/10.1001\/archderm.139.9.1121 .","journal-title":"Arch Dermatol"},{"key":"349_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fimmu.2018.00248","volume":"9","author":"A Lamberts","year":"2018","unstructured":"Lamberts A, Euverman HI, Terra JB, Jonkman MF, Horv\u00e1th B. Effectiveness and safety of rituximab in recalcitrant pemphigoid diseases. Front Immunol. 2018;9:248. https:\/\/doi.org\/10.3389\/fimmu.2018.00248 .","journal-title":"Front Immunol"},{"issue":"2","key":"349_CR24","first-page":"163","volume":"148","author":"E Antiga","year":"2013","unstructured":"Antiga E, Verdelli A, Calabr\u00f2 A, Fabbri P, Caproni M. Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience. G Ital Dermatol Venereol. 2013;148(2):163\u20139.","journal-title":"G Ital Dermatol Venereol"},{"issue":"5","key":"349_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.0736-8046.2004.21509.x","volume":"21","author":"GR Powell","year":"2004","unstructured":"Powell GR, Bruckner AL, Weston WL. Dermatitis herpetiformis presenting as chronic urticaria. Pediatr Dermatol. 2004;21(5):564\u20137. https:\/\/doi.org\/10.1111\/j.0736-8046.2004.21509.x .","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"349_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1525-1470.2011.01401.x","volume":"29","author":"J Heinlin","year":"2012","unstructured":"Heinlin J, Knoppke B, Kohl E, Landthaler M, Karrer S. Dermatitis herpetiformis presenting as digital petechiae. Pediatr Dermatol. 2012;29(2):209\u201312. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01401.x .","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"349_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/DAD.0000000000000420","volume":"38","author":"MA Barnadas","year":"2016","unstructured":"Barnadas MA. Dermatitis herpetiformis: a review of direct immunofluorescence findings. Am J Dermatopathol. 2016;38(4):283\u20138. https:\/\/doi.org\/10.1097\/DAD.0000000000000420 .","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"349_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1046\/j.1525-1470.2002.00096.x","volume":"19","author":"L Sousa","year":"2002","unstructured":"Sousa L, Bajanca R, Cabral J, Fiadeiro T. Dermatitis herpetiformis: should direct immunofluorescence be the only diagnostic criterion? Pediatr Dermatol. 2002;19(4):336\u20139.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"349_CR29","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jaad.2010.09.776","volume":"64","author":"D Bolotin","year":"2011","unstructured":"Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol. 2011;64(6):1027\u201333. https:\/\/doi.org\/10.1016\/j.jaad.2010.09.776 (quiz 1033\u20131024).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"349_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0190-9622(86)70137-0","volume":"15","author":"E Ermacora","year":"1986","unstructured":"Ermacora E, Prampolini L, Tribbia G, Pezzoli G, Gelmetti C, Cucchi G, et al. Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol. 1986;15(1):24\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"349_CR31","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/bjd.13047","volume":"171","author":"K Hervonen","year":"2014","unstructured":"Hervonen K, Salmi TT, Kurppa K, Kaukinen K, Collin P, Reunala T. Dermatitis herpetiformis in children: a long-term follow-up study. Br J Dermatol. 2014;171(5):1242\u20133. https:\/\/doi.org\/10.1111\/bjd.13047 .","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.7326\/0003-4819-102-2-194","volume":"102","author":"MJ Cunningham","year":"1985","unstructured":"Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis. Prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med. 1985;102(2):194\u20136.","journal-title":"Ann Intern Med"},{"issue":"1","key":"349_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2133.2004.05642.x","volume":"150","author":"K Hervonen","year":"2004","unstructured":"Hervonen K, Viljamaa M, Collin P, Knip M, Reunala T. The occurrence of type 1 diabetes in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol. 2004;150(1):136\u20138.","journal-title":"Br J Dermatol"},{"issue":"3","key":"349_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2001.114733","volume":"45","author":"YI Zhu","year":"2001","unstructured":"Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45(3):420\u201334. https:\/\/doi.org\/10.1067\/mjd.2001.114733 .","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"349_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jamadermatol.2016.4676","volume":"153","author":"LN Albers","year":"2017","unstructured":"Albers LN, Zone JJ, Stoff BK, Feldman RJ. Rituximab treatment for recalcitrant dermatitis herpetiformis. JAMA Dermatol. 2017;153(3):315\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2016.4676 .","journal-title":"JAMA Dermatol"},{"issue":"9","key":"349_CR36","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1046\/j.1365-4362.1999.00764.x","volume":"38","author":"B Bjarnason","year":"1999","unstructured":"Bjarnason B, Flosad\u00f3ttir E. Childhood, neonatal, and stillborn pemphigus vulgaris. Int J Dermatol. 1999;38(9):680\u20138.","journal-title":"Int J Dermatol"},{"issue":"3","key":"349_CR37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/pde.13152","volume":"34","author":"CM Peterman","year":"2017","unstructured":"Peterman CM, Vadeboncoeur S, Schmidt BA, Gellis SE. Pediatric pemphigus herpetiformis: case report and review of the literature. Pediatr Dermatol. 2017;34(3):342\u20136. https:\/\/doi.org\/10.1111\/pde.13152 .","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"349_CR38","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1111\/pde.12649","volume":"32","author":"JJ Schoch","year":"2015","unstructured":"Schoch JJ, Boull CL, Camilleri MJ, Tollefson MM, Hook KP, Polcari IC. Transplacental transmission of pemphigus herpetiformis in the setting of maternal lymphoma. Pediatr Dermatol. 2015;32(6):e234\u20137. https:\/\/doi.org\/10.1111\/pde.12649 .","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"349_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1525-1470.2005.22408.x","volume":"22","author":"AL Bruckner","year":"2005","unstructured":"Bruckner AL, Fitzpatrick JE, Hashimoto T, Weston WL, Morelli JG. Atypical IgA\/IgG pemphigus involving the skin, oral mucosa, and colon in a child: a novel variant of IgA pemphigus? Pediatr Dermatol. 2005;22(4):321\u20137. https:\/\/doi.org\/10.1111\/j.1525-1470.2005.22408.x .","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"349_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4103\/0378-6323.181467","volume":"82","author":"KC Neethu","year":"2016","unstructured":"Neethu KC, Rao R, Balachandran C, Pai S. Juvenile IgA pemphigus: a case report and review of literature. Indian J Dermatol Venereol Leprol. 2016;82(4):439\u201342. https:\/\/doi.org\/10.4103\/0378-6323.181467 .","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"349_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/00015550410025895","volume":"84","author":"GM Palleschi","year":"2004","unstructured":"Palleschi GM, Giomi B, Giacomelli A. Juvenile pemphigus vegetans of the glans penis. Acta Derm Venereol. 2004;84(4):316\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"349_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/ced.13796","volume":"44","author":"N Tani","year":"2019","unstructured":"Tani N, Sugita K, Ishii N, Wakumoto K, Hashimoto T, Yamamoto O. Juvenile pemphigus vulgaris manifesting as vegetating skin lesions. Clin Exp Dermatol. 2019;44(5):559\u201361. https:\/\/doi.org\/10.1111\/ced.13796 .","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"349_CR43","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1111\/bjd.15954","volume":"177","author":"JS Leventhal","year":"2017","unstructured":"Leventhal JS, Haberland CM, Cowper SE, Tomayko MM. Image gallery: juvenile autoimmune pemphigus presenting with diffuse gingival hypertrophy and antibodies against desmocollin 3. Br J Dermatol. 2017;177(5):e226. https:\/\/doi.org\/10.1111\/bjd.15954 .","journal-title":"Br J Dermatol"},{"issue":"5","key":"349_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1525-1470.2011.01514.x","volume":"28","author":"D Mabrouk","year":"2011","unstructured":"Mabrouk D, Ahmed AR. Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris. Pediatr Dermatol. 2011;28(5):485\u201393. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01514.x .","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"349_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/11310380-000000000-00000","volume":"11","author":"A Asarch","year":"2010","unstructured":"Asarch A, G\u00fcrcan HM, Ahmed AR. A current review of juvenile pemphigus vulgaris: analysis of data on clinical outcomes. Am J Clin Dermatol. 2010;11(1):21\u201333. https:\/\/doi.org\/10.2165\/11310380-000000000-00000 .","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"349_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1525-1470.2012.01730.x","volume":"30","author":"A Baratta","year":"2013","unstructured":"Baratta A, Camarillo D, Papa C, Treat JR, Payne AS, Rozenber SS, et al. Pediatric pemphigus vulgaris: durable treatment responses achieved with prednisone and mycophenolate mofetil (MMF). Pediatr Dermatol. 2013;30(2):240\u20134. https:\/\/doi.org\/10.1111\/j.1525-1470.2012.01730.x .","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"349_CR47","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","volume":"142","author":"S Beissert","year":"2006","unstructured":"Beissert S, Werfel T, Frieling U, B\u00f6hm M, Sticherling M, Stadler R, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006;142(11):1447\u201354. https:\/\/doi.org\/10.1001\/archderm.142.11.1447 .","journal-title":"Arch Dermatol"},{"issue":"2","key":"349_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1525-1470.2008.00808.x","volume":"26","author":"A Asarch","year":"2009","unstructured":"Asarch A, Razzaque Ahmed A. Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulin therapy. Pediatr Dermatol. 2009;26(2):197\u2013202. https:\/\/doi.org\/10.1111\/j.1525-1470.2008.00808.x .","journal-title":"Pediatr Dermatol"},{"issue":"10083","key":"349_CR49","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","volume":"389","author":"P Joly","year":"2017","unstructured":"Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, et al. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. Lancet. 2017;389(10083):2031\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(17)30070-3 .","journal-title":"Lancet"},{"issue":"2","key":"349_CR50","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1111\/pde.12744","volume":"33","author":"L Kincaid","year":"2016","unstructured":"Kincaid L, Weinstein M. Rituximab therapy for childhood pemphigus vulgaris. Pediatr Dermatol. 2016;33(2):e61\u20134. https:\/\/doi.org\/10.1111\/pde.12744 .","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"349_CR51","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaad.2014.05.071","volume":"71","author":"K Vinay","year":"2014","unstructured":"Vinay K, Kanwar AJ, Sawatkar GU, Dogra S, Ishii N, Hashimoto T. Successful use of rituximab in the treatment of\u00a0childhood and juvenile pemphigus. J Am Acad Dermatol. 2014;71(4):669\u201375. https:\/\/doi.org\/10.1016\/j.jaad.2014.05.071 .","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"349_CR52","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1111\/j.1468-3083.2011.04391.x","volume":"27","author":"AJ Kanwar","year":"2013","unstructured":"Kanwar AJ, Tsuruta D, Vinay K, Koga H, Ishii N, Dainichi T, et al. Efficacy and safety of rituximab treatment in Indian pemphigus patients. J Eur Acad Dermatol Venereol. 2013;27(1):e17\u201323. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04391.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"349_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/1523-1747.ep13070394","volume":"92","author":"LA Diaz","year":"1989","unstructured":"Diaz LA, Sampaio SA, Rivitti EA, Martins CR, Cunha PR, Lombardi C, et al. Endemic pemphigus foliaceus (Fogo Selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol. 1989;92(1):4\u201312.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"349_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1067\/mjd.2002.119647","volume":"46","author":"DW Metry","year":"2002","unstructured":"Metry DW, Hebert AA, Jordon RE. Nonendemic pemphigus foliaceus in children. J Am Acad Dermatol. 2002;46(3):419\u201322.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"349_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1525-1470.2007.00369.x","volume":"24","author":"EA Connelly","year":"2007","unstructured":"Connelly EA, Aber C, Kleiner G, Nousari C, Charles C, Schachner LA. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment. Pediatr Dermatol. 2007;24(2):172\u20136. https:\/\/doi.org\/10.1111\/j.1525-1470.2007.00369.x .","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"349_CR56","first-page":"471","volume":"70","author":"BT Yu","year":"1987","unstructured":"Yu BT, Piamphongsant T. Exfoliative type juvenile pemphigus foliaceus: a case report. J Med Assoc Thai. 1987;70(8):471\u20134.","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"349_CR57","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2133.2009.09224.x","volume":"161","author":"A Mlynek","year":"2009","unstructured":"Mlynek A, B\u00e4r M, Bauer A, Meurer M. Juvenile pemphigus foliaceus associated with severe nonscarring alopecia. Br J Dermatol. 2009;161(2):472\u20134. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09224.x .","journal-title":"Br J Dermatol"},{"issue":"1","key":"349_CR58","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1111\/pde.12729","volume":"33","author":"S Geller","year":"2016","unstructured":"Geller S, Gat A, Harel A, Mashiah J, Zeeli T, Eming R, et al. Childhood pemphigus foliaceus with exclusive immunoglobulin G autoantibodies to desmocollins. Pediatr Dermatol. 2016;33(1):e10\u20133. https:\/\/doi.org\/10.1111\/pde.12729 .","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"349_CR59","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1111\/pde.13051","volume":"34","author":"R Laarman","year":"2017","unstructured":"Laarman R, Horii KA. Concurrent pemphigus foliaceus and graves\u2019 disease. Pediatr Dermatol. 2017;34(2):e95\u20136. https:\/\/doi.org\/10.1111\/pde.13051 .","journal-title":"Pediatr Dermatol"},{"issue":"1\u20132","key":"349_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jns.2012.05.007","volume":"319","author":"R Salazar","year":"2012","unstructured":"Salazar R, Cerghet M, Farhat E, Lim HW. Neuromyelitis optica in a patient with pemphigus foliaceus. J Neurol Sci. 2012;319(1\u20132):152\u20135. https:\/\/doi.org\/10.1016\/j.jns.2012.05.007 .","journal-title":"J Neurol Sci"},{"key":"349_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/archderm.1961.01580070058007","volume":"83","author":"HO Perry","year":"1961","unstructured":"Perry HO. Pemphigus foliaceus. Arch Dermatol. 1961;83:52\u201372.","journal-title":"Arch Dermatol"},{"issue":"5","key":"349_CR62","doi-asserted-by":"publisher","first-page":"1062.e1061","DOI":"10.1016\/j.jpeds.2014.07.023","volume":"165","author":"A Adah","year":"2014","unstructured":"Adah A, Hill K, Wyatt J, Didion L. Pemphigus foliaceus in an adolescent. J Pediatr. 2014;165(5):1062.e1061. https:\/\/doi.org\/10.1016\/j.jpeds.2014.07.023 .","journal-title":"J Pediatr"},{"key":"349_CR63","doi-asserted-by":"crossref","unstructured":"Loh TY, Paravar T. Rituximab in the management of juvenile pemphigus foliaceus. Dermatol Online J. 2017;23(6). Retrieved from https:\/\/escholarship.org\/uc\/item\/0415n1r5 .","DOI":"10.5070\/D3236035373"},{"issue":"4","key":"349_CR64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.bmt.1704808","volume":"35","author":"AL Herr","year":"2005","unstructured":"Herr AL, Hatami A, Kokta V, Dalle JH, Champagne MA, Duval M. Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Bone Marrow Transpl. 2005;35(4):427\u20138. https:\/\/doi.org\/10.1038\/sj.bmt.1704808 .","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"349_CR65","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","volume":"147","author":"D Mimouni","year":"2002","unstructured":"Mimouni D, Anhalt GJ, Lazarova Z, Aho S, Kazerounian S, Kouba DJ, et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol. 2002;147(4):725\u201332.","journal-title":"Br J Dermatol"},{"issue":"1","key":"349_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/1756-185x.13407","volume":"22","author":"SP Han","year":"2019","unstructured":"Han SP, Fu LS, Chen LJ. Masked pemphigus among pediatric patients with Castleman\u2019s disease. Int J Rheum Dis. 2019;22(1):121\u201331. https:\/\/doi.org\/10.1111\/1756-185x.13407 .","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"349_CR67","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/bjd.14162","volume":"173","author":"A Ohzono","year":"2015","unstructured":"Ohzono A, Sogame R, Li X, Teye K, Tsuchisaka A, Numata S, et al. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015;173(6):1447\u201352. https:\/\/doi.org\/10.1111\/bjd.14162 .","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR68","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/JID.2015.408","volume":"136","author":"A Tsuchisaka","year":"2016","unstructured":"Tsuchisaka A, Numata S, Teye K, Natsuaki Y, Kawakami T, Takeda Y, et al. Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients. J Invest Dermatol. 2016;136(2):399\u2013408. https:\/\/doi.org\/10.1038\/JID.2015.408 .","journal-title":"J Invest Dermatol"},{"issue":"5","key":"349_CR69","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1525-1470.2011.01670.x","volume":"29","author":"M Daneshpazhooh","year":"2012","unstructured":"Daneshpazhooh M, Moeineddin F, Kiani A, Naraghi ZS, Firooz A, Akhyani M, et al. Fatal paraneoplastic pemphigus after removal of Castleman\u2019s disease in a child. Pediatr Dermatol. 2012;29(5):656\u20137. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01670.x .","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"349_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","volume":"58","author":"O Waisbourd-Zinman","year":"2008","unstructured":"Waisbourd-Zinman O, Ben-Amitai D, Cohen AD, Feinmesser M, Mimouni D, Adir-Shani A, et al. Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol. 2008;58(1):41\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2007.08.010 .","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"349_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/2229-5178.131101","volume":"5","author":"D Das","year":"2014","unstructured":"Das D, Bandyopadhyay D. Juvenile pemphigoid nodularis: report of a rare case. Indian Dermatol Online J. 2014;5(2):189\u201392. https:\/\/doi.org\/10.4103\/2229-5178.131101 .","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"349_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaad.2005.08.047","volume":"55","author":"JL McGinness","year":"2006","unstructured":"McGinness JL, Bivens MM, Greer KE, Patterson JW, Saulsbury FT. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol. 2006;55(1):143\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2005.08.047 .","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"349_CR73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2133.1994.tb06899.x","volume":"130","author":"RC Ratnavel","year":"1994","unstructured":"Ratnavel RC, Shanks AJ, Grant JW, Norris PG. Juvenile pemphigoid nodularis. Br J Dermatol. 1994;130(1):125\u20136.","journal-title":"Br J Dermatol"},{"issue":"4","key":"349_CR74","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/0019-5154.160534","volume":"60","author":"Y Khatib","year":"2015","unstructured":"Khatib Y, Makhija M, Patel RD, Karad G. Pemphigoid vegetans in childhood: a case report and short review of literature. Indian J Dermatol. 2015;60(4):422. https:\/\/doi.org\/10.4103\/0019-5154.160534 .","journal-title":"Indian J Dermatol"},{"issue":"5","key":"349_CR75","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1590\/abd1806-4841.20174949","volume":"92","author":"S Dayal","year":"2017","unstructured":"Dayal S, Sahu P, Jain VK. Dyshidrosiform pemphigoid localized on the hands in a child: a rare occurrence. An Bras Dermatol. 2017;92(5):714\u20136. https:\/\/doi.org\/10.1590\/abd1806-4841.20174949 .","journal-title":"An Bras Dermatol"},{"issue":"5","key":"349_CR76","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1365-2133.2007.07810.x","volume":"156","author":"N Yamane","year":"2007","unstructured":"Yamane N, Sawamura D, Nishie W, Abe M, Kodama K, Adachi K, et al. Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone. Br J Dermatol. 2007;156(5):1075\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07810.x .","journal-title":"Br J Dermatol"},{"issue":"1","key":"349_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaad.2010.02.034","volume":"65","author":"C Mammen","year":"2011","unstructured":"Mammen C, White CT, Prendiville J. Childhood bullous pemphigoid: a rare manifestation of chronic renal allograft rejection. J Am Acad Dermatol. 2011;65(1):217\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2010.02.034 .","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"349_CR78","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/pde.12231","volume":"30","author":"S de la Fuente","year":"2013","unstructured":"de la Fuente S, Hern\u00e1ndez-Mart\u00edn \u00c1, de Lucas R, Gonz\u00e1lez-Ense\u00f1at MA, Vicente A, Colmenero I, et al. Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review. Pediatr Dermatol. 2013;30(6):741\u20134. https:\/\/doi.org\/10.1111\/pde.12231 .","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"349_CR79","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","volume":"142","author":"K Muramatsu","year":"2018","unstructured":"Muramatsu K, Ujiie H, Kobayashi I, Nishie W, Izumi K, Ito T, et al. Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects. J Allergy Clin Immunol. 2018;142(6):1818\u201330. https:\/\/doi.org\/10.1016\/j.jaci.2018.03.014 (e1816).","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"349_CR80","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jaci.2018.08.028","volume":"142","author":"T Hashimoto","year":"2018","unstructured":"Hashimoto T, Takahashi H, Sakaguchi S. Regulatory T-cell deficiency and autoimmune skin disease: beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J Allergy Clin Immunol. 2018;142(6):1754\u20136. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.028 .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"349_CR81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1468-3083.2009.03264.x","volume":"24","author":"M Gajic-Veljic","year":"2010","unstructured":"Gajic-Veljic M, Nikolic M, Medenica L. Juvenile bullous pemphigoid: the presentation and follow-up of six cases. J Eur Acad Dermatol Venereol. 2010;24(1):69\u201372. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03264.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2 Pt 2","key":"349_CR82","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0190-9622(99)70481-0","volume":"40","author":"RM Tr\u00fceb","year":"1999","unstructured":"Tr\u00fceb RM, Didierjean L, Fellas A, Elias A, Borradori L. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens. J Am Acad Dermatol. 1999;40(2 Pt 2):338\u201344.","journal-title":"J Am Acad Dermatol"},{"key":"349_CR83","doi-asserted-by":"crossref","unstructured":"Seminario-Vidal L, Sami N, Miller J, Theos A. Mycophenolate mofetil therapy for pediatric bullous pemphigoid. Dermatol Online J. 2015;21(8). Retrieved from https:\/\/escholarship.org\/uc\/item\/3x5585zn .","DOI":"10.5070\/D3218028429"},{"issue":"5","key":"349_CR84","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/pde.12635","volume":"32","author":"B Tekin","year":"2015","unstructured":"Tekin B, Y\u00fccelten AD. Infantile bullous pemphigoid treated using intravenous immunoglobulin: case report and review of the literature. Pediatr Dermatol. 2015;32(5):723\u20136. https:\/\/doi.org\/10.1111\/pde.12635 .","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"349_CR85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jca.20115","volume":"22","author":"G Tripodi","year":"2007","unstructured":"Tripodi G, Risso M, Tenerini L, Gandullia P, Castellano E, Rivabella L. Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy. J Clin Apher. 2007;22(1):26\u201330. https:\/\/doi.org\/10.1002\/jca.20115 .","journal-title":"J Clin Apher"},{"issue":"5","key":"349_CR86","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1111\/pde.12057","volume":"30","author":"I Fuertes","year":"2013","unstructured":"Fuertes I, Luelmo J, Leal L, Roman\u00ed J, S\u00e1nchez S, Mascar\u00f3 JM. Refractory childhood pemphigoid successfully treated with rituximab. Pediatr Dermatol. 2013;30(5):e96\u20137. https:\/\/doi.org\/10.1111\/pde.12057 .","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"349_CR87","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bmt.1703654","volume":"30","author":"P Szabolcs","year":"2002","unstructured":"Szabolcs P, Reese M, Yancey KB, Hall RP, Kurtzberg J. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transpl. 2002;30(5):327\u20139. https:\/\/doi.org\/10.1038\/sj.bmt.1703654 .","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"349_CR88","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","volume":"156","author":"E Schmidt","year":"2007","unstructured":"Schmidt E, Seitz CS, Benoit S, Br\u00f6cker EB, Goebeler M. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol. 2007;156(2):352\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07646.x .","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1525-1470.2009.01079.x","volume":"27","author":"M Kharfi","year":"2010","unstructured":"Kharfi M, Khaled A, Anane R, Fazaa B, Kamoun MR. Early onset childhood cicatricial pemphigoid: a case report and review of the literature. Pediatr Dermatol. 2010;27(2):119\u201324. https:\/\/doi.org\/10.1111\/j.1525-1470.2009.01079.x .","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"349_CR90","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1111\/pde.12210","volume":"31","author":"E Kahn","year":"2014","unstructured":"Kahn E, Spence Shishido A, Yancey KB, Lawley LP. Anti-laminin-332 mucous membrane pemphigoid in a 9-year old girl. Pediatr Dermatol. 2014;31(3):e76\u20139. https:\/\/doi.org\/10.1111\/pde.12210 .","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"349_CR91","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaad.2009.02.012","volume":"61","author":"C Rose","year":"2009","unstructured":"Rose C, Schmidt E, Kerstan A, Thoma-Uszynski S, Wesselmann U, K\u00e4sbohrer U, et al. Histopathology of anti-laminin 5 mucous membrane pemphigoid. J Am Acad Dermatol. 2009;61(3):433\u201340. https:\/\/doi.org\/10.1016\/j.jaad.2009.02.012 .","journal-title":"J Am Acad Dermatol"},{"key":"349_CR92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/1735-1995.183992","volume":"21","author":"S Tavakolpour","year":"2016","unstructured":"Tavakolpour S. The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: a review of literature. J Res Med Sci. 2016;21:37. https:\/\/doi.org\/10.4103\/1735-1995.183992 .","journal-title":"J Res Med Sci"},{"issue":"5","key":"349_CR93","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2016.01.020","volume":"74","author":"A Maley","year":"2016","unstructured":"Maley A, Warren M, Haberman I, Swerlick R, Kharod-Dholakia B, Feldman R. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). J Am Acad Dermatol. 2016;74(5):835\u201340. https:\/\/doi.org\/10.1016\/j.jaad.2016.01.020 .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"349_CR94","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1365-2133.2006.07443.x","volume":"155","author":"M Mayuzumi","year":"2006","unstructured":"Mayuzumi M, Akiyama M, Nishie W, Ukae S, Abe M, Sawamura D, et al. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol. 2006;155(5):1048\u201352. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07443.x .","journal-title":"Br J Dermatol"},{"issue":"5","key":"349_CR95","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1525-1470.2011.01509.x","volume":"29","author":"B Yang","year":"2012","unstructured":"Yang B, Wang C, Wang N, Pan F, Chen S, Zhou G, et al. Childhood epidermolysis bullosa acquisita: report of a Chinese case. Pediatr Dermatol. 2012;29(5):614\u20137. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01509.x .","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"349_CR96","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archdermatol.2010.317","volume":"147","author":"ML Abrams","year":"2011","unstructured":"Abrams ML, Smidt A, Benjamin L, Chen M, Woodley D, Mancini AJ. Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant. Arch Dermatol. 2011;147(3):337\u201341. https:\/\/doi.org\/10.1001\/archdermatol.2010.317 .","journal-title":"Arch Dermatol"},{"issue":"2","key":"349_CR97","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/bjd.14764","volume":"176","author":"L Guerra","year":"2017","unstructured":"Guerra L, Pacifico V, Calabresi V, De Luca N, Castiglia D, Angelo C, et al. Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata. Br J Dermatol. 2017;176(2):491\u20134. https:\/\/doi.org\/10.1111\/bjd.14764 .","journal-title":"Br J Dermatol"},{"issue":"4","key":"349_CR98","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jaad.2005.07.009","volume":"54","author":"MM Tran","year":"2006","unstructured":"Tran MM, Anhalt GJ, Barrett T, Cohen BA. Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent. J Am Acad Dermatol. 2006;54(4):734\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2005.07.009 .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"349_CR99","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1365-2133.1999.03163.x","volume":"141","author":"JW Bauer","year":"1999","unstructured":"Bauer JW, Schaeppi H, Metze D, Muss W, Pohla-Gubo G, Hametner R, et al. Ocular involvement in IgA-epidermolysis bullosa acquisita. Br J Dermatol. 1999;141(5):887\u201392.","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR100","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2133.1997.18191915.x","volume":"137","author":"F Caux","year":"1997","unstructured":"Caux F, Kirtschig G, Lemarchand-Venencie F, Venencie PY, Hoang-Xuan T, Robin H, et al. IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol. 1997;137(2):270\u20135.","journal-title":"Br J Dermatol"},{"issue":"6","key":"349_CR101","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","volume":"70","author":"JD Fine","year":"2014","unstructured":"Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103\u201326. https:\/\/doi.org\/10.1016\/j.jaad.2014.01.903 .","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"349_CR102","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1046\/j.1365-2133.2001.04198.x","volume":"144","author":"A Stouthamer","year":"2001","unstructured":"Stouthamer A, Nieboer C, van der Waal RI, Jonkman MF. Normal expression of the 19-DEJ-1 epitope in two siblings with late-onset junctional epidermolysis bullosa. Br J Dermatol. 2001;144(5):1054\u20137.","journal-title":"Br J Dermatol"},{"issue":"2","key":"349_CR103","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","volume":"60","author":"JD Fine","year":"2009","unstructured":"Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006. J Am Acad Dermatol. 2009;60(2):203\u201311. https:\/\/doi.org\/10.1016\/j.jaad.2008.09.035 .","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"349_CR104","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5582\/irdr.2017.01005","volume":"6","author":"E Rashidghamat","year":"2017","unstructured":"Rashidghamat E, McGrath JA. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis Res. 2017;6(1):6\u201320. https:\/\/doi.org\/10.5582\/irdr.2017.01005 .","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"349_CR105","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaad.2015.01.002","volume":"72","author":"CS Yang","year":"2015","unstructured":"Yang CS, Kim C, Antaya RJ. Review of thalidomide use in the pediatric population. J Am Acad Dermatol. 2015;72(4):703\u201311. https:\/\/doi.org\/10.1016\/j.jaad.2015.01.002 .","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"349_CR106","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/1346-8138.13406","volume":"43","author":"T Takahashi","year":"2016","unstructured":"Takahashi T, Mizutani Y, Ito M, Nakano H, Sawamura D, Seishima M. Dystrophic epidermolysis bullosa pruriginosa successfully treated with immunosuppressants. J Dermatol. 2016;43(11):1391\u20132. https:\/\/doi.org\/10.1111\/1346-8138.13406 .","journal-title":"J Dermatol"},{"issue":"5","key":"349_CR107","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1684\/ejd.2013.2126","volume":"23","author":"M Tarutani","year":"2013","unstructured":"Tarutani M, Shiga T, Nakajima K, Nakano H, Sawamura D, Sano S. Dystrophic epidermolysis bullosa pruriginosa in a mother and daughter successfully treated by low dose cyclosporine. Eur J Dermatol. 2013;23(5):727\u20139. https:\/\/doi.org\/10.1684\/ejd.2013.2126 .","journal-title":"Eur J Dermatol"},{"issue":"2","key":"349_CR108","first-page":"308","volume":"137","author":"H Yamasaki","year":"1997","unstructured":"Yamasaki H, Tada J, Yoshioka T, Arata J. Epidermolysis bullosa pruriginosa (McGrath) successfully controlled by oral cyclosporin. Br J Dermatol. 1997;137(2):308\u201310.","journal-title":"Br J Dermatol"},{"issue":"4","key":"349_CR109","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2003.08.008","volume":"50","author":"JD Fine","year":"2004","unstructured":"Fine JD, Johnson LB, Weiner M, Stein A, Suchindran C. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin. J Am Acad Dermatol. 2004;50(4):563\u201371. https:\/\/doi.org\/10.1016\/j.jaad.2003.08.008 .","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"349_CR110","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1080\/14760584.2016.1193438","volume":"15","author":"DR Cheng","year":"2016","unstructured":"Cheng DR, Barton R, Greenway A, Crawford NW. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Rev Vaccines. 2016;15(12):1567\u201374. https:\/\/doi.org\/10.1080\/14760584.2016.1193438 .","journal-title":"Expert Rev Vaccines"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-019-00349-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-019-00349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T05:09:36Z","timestamp":1721711376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-019-00349-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s40272-019-00349-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"10 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Schultz and Dr. Hook have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}